Chapter References

The Big Heart Disease Lie

Effective Home Treatments for Heart Disease

Get Instant Access

1. Guidelines for Cardiopulmonary Resuscitation and Emergency Care: Recommendation of the 1992 National Conference: Part III. Adult cardiac life support. JAMA 268:2205, 1992.

2. Echt D, Leibson P, Mitchell L, et al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo: Ihe Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781, 1991.

3. Kowey P, Marinchak R, Rial S, et al: Pharmacologic and pharmacokinetics profile of class III antidysrhythmic drugs. Am J Cardiol 80:8A, 16G.

4. Kostis J, Lacy B, Cosgrove N, et al: Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction. Am Heart J 133:550, 1997.

5. Hagar WD, Davis B, Riba A, et al: Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: Ihe SAVE study experience. Am Heart J 135:406, 1998.

6. Gulamhusein S, Ko P, Klein GJ: Ventricular fibrillation following verapamil. A Wolff-Parkinson-White syndrome. Am Heart J 106:145, 1983.

7. Strasberg B, Sagie A, Rechavia E, et al: Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation. Cardiovasc Drugs Ther, 2(6):801, 1989.

8. McGovern B, Garan H, Ruskin JN: Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med 104:791, 1986.

9. Shryock J, Belardinelli L: Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2, 1997.

10. Marco CA, Cardinale JF: Adenosine for the treatment of supraventricular tachycardia in the ED. Am J Emerg Med 12:485, 1994.

11. Ryan I, Anderson J, Antonan E, et al: ACC/AHA Guidelines for the Management of Patients with Acute Myocardial Infarction: executive summary. J Am Coll Cardiol 28(5):1372, 1996.

12. Woods K, Fletcher S, Roffe C, et al: Intravenous magnesium sulfate in suspected myocardial infarction: Ihe Second Leicester Intravenous Magnesium Trial (LIMII-2). Lancet 339:1553, 1992.

13. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: A randomized factorial trial assessing oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected myocardial infarction. Lancet 345:669, 1995.

14. Frakes M, Richardson L: Magnesium sulfate therapy in certain emergency conditions. Am J Emerg Med 15:182, 1997.

Was this article helpful?

0 0
Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook

Post a comment